Cvrx Inc Stock Today
| CVRX Stock | USD 16.85 0.47 2.71% |
Performance9 of 100
| Odds Of DistressLess than 43
|
CVRx is trading at 16.85 as of the 29th of January 2025; that is 2.71 percent decrease since the beginning of the trading day. The stock's open price was 17.32. CVRx has about a 43 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 1st of October 2024 and ending today, the 29th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 30th of June 2021 | Category Healthcare | Classification Health Care |
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. The company has 24.26 M outstanding shares of which 2.04 M shares are currently shorted by private and institutional investors with about 10.35 trading days to cover. More on CVRx Inc
Moving together with CVRx Stock
| 0.77 | CAH | Cardinal Health Earnings Call Tomorrow | PairCorr |
Moving against CVRx Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
CVRx Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Nadim Yared | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCVRx can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CVRx's financial leverage. It provides some insight into what part of CVRx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CVRx Inc (CVRX) is traded on NASDAQ Exchange in USA. It is located in 9201 West Broadway Avenue, Minneapolis, MN, United States, 55445 and employs 200 people. CVRx is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 423.49 M. CVRx Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 24.26 M outstanding shares of which 2.04 M shares are currently shorted by private and institutional investors with about 10.35 trading days to cover.
CVRx Inc currently holds about 109.98 M in cash with (39.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.34.
Check CVRx Probability Of Bankruptcy
Ownership AllocationCVRx holds a total of 24.26 Million outstanding shares. Over half of CVRx's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CVRx Ownership Details
CVRx Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Emerald Mutual Fund Advisers Trust | 2024-09-30 | 287.8 K | |
| State Street Corp | 2024-09-30 | 264.7 K | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 231.3 K | |
| Nuveen Asset Management, Llc | 2024-09-30 | 210.1 K | |
| Norges Bank | 2024-06-30 | 149.2 K | |
| Mairs & Power Inc | 2024-09-30 | 144.4 K | |
| Northern Trust Corp | 2024-09-30 | 133.2 K | |
| Marshall Wace Asset Management Ltd | 2024-09-30 | 115.7 K | |
| Goldman Sachs Group Inc | 2024-09-30 | 112.3 K | |
| Johnson & Johnson | 2024-09-30 | 4.1 M | |
| Nea Management Company, Llc | 2024-09-30 | 2.4 M |
CVRx Historical Income Statement
CVRx Stock Against Markets
CVRx Corporate Management
| RN MBA | Reimbursement, Access | Profile | |
| Tonya SPHR | Chief Officer | Profile | |
| Jared Oasheim | Chief Officer | Profile | |
| Paul Verrastro | Chief Officer | Profile | |
| Craig Palmer | Senior Sales | Profile |
Additional Tools for CVRx Stock Analysis
When running CVRx's price analysis, check to measure CVRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVRx is operating at the current time. Most of CVRx's value examination focuses on studying past and present price action to predict the probability of CVRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVRx's price. Additionally, you may evaluate how the addition of CVRx to your portfolios can decrease your overall portfolio volatility.